Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael M. Abecassis currently holds 119,170 shares of PharmaCyte Biotech, Inc. (PMCB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael M. Abecassis has been a net neutral trader of PMCB stock. They have purchased $0 and sold $0 worth of shares.
Michael M. Abecassis's most recent insider trade was on Mar 31, 2026, when they sold 119,170 shares at $0.00 per share.
Michael M. Abecassis serves as Executive at PharmaCyte Biotech, Inc. (PMCB). They have executed 4 insider transactions totaling $0 over their tenure at the company.
Michael M. Abecassis holds the position of Executive at PharmaCyte Biotech, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Michael M. Abecassis has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Michael M. Abecassis was on Dec 12, 2025, when they sold $17.2K worth of PMCB shares. This transaction involved 16,875 shares at $1.02 per share.
Michael M. Abecassis currently owns 119,170 shares of PharmaCyte Biotech, Inc. (PMCB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael M. Abecassis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael M. Abecassis has 4 Form 4 filings on record as an insider at PharmaCyte Biotech, Inc..
Set alerts for Michael M. Abecassis and 40,000+ other insiders.